EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurodevelopmental defects in a mouse model of O- GlcNAc transferase intellectual disability

Florence Authier iD, Nina Ondruskova, Andrew T Ferenbach, Alison D McNeilly, Daan M F van Aalten iD

Disease Models & Mechanisms · 2024

DOI: 10.1242/dmm.050671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Florence Authier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus, Denmark. Hauptthemen laut MEDLINE: N-Acetylglucosaminyltransferases, Intellectual Disability, Disease Models, Animal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The addition of O-linked β-N-acetylglucosamine (O-GlcNAc) to proteins (referred to as O-GlcNAcylation) is a modification that is crucial for vertebrate development. O-GlcNAcylation is catalyzed by O-GlcNAc transferase (OGT) and reversed by O-GlcNAcase (OGA). Missense variants of OGT have recently been shown to segregate with an X-linked syndromic form of intellectual disability, OGT-linked congenital disorder of glycosylation (OGT-CDG). Although the existence of OGT-CDG suggests that O-GlcNAcylation is crucial for neurodevelopment and/or cognitive function, the underlying pathophysiologic mechanisms remain unknown. Here we report a mouse line that carries a catalytically impaired OGT-CDG variant. These mice show altered O-GlcNAc homeostasis with decreased global O-GlcNAcylation and reduced levels of OGT and OGA in the brain. Phenotypic characterization of the mice revealed lower body weight associated with reduced body fat mass, short stature and microcephaly. This mouse model will serve as an important tool to study genotype-phenotype correlations in OGT-CDG in vivo and for the development of possible treatment avenues for this disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-AcetylglucosaminyltransferasesIntellectual DisabilityDisease Models, AnimalAnimalsBrainPhenotypeMiceNeurodevelopmental Disordersbeta-N-AcetylhexosaminidasesGlycosylationBody Weight

Stichwörter der Autor:innen

O-GlcNAcylationIntellectual disabilityVertebrate development

Substanzen

N-AcetylglucosaminyltransferasesO-GlcNAc transferasebeta-N-Acetylhexosaminidaseshexosaminidase C

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus, Denmark.
  • Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, 128 08 Praha 2, Czech Republic.
  • Division of Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
  • Division of Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.

ORCID-Profile: Florence Authier, Daan M F van Aalten

Förderung

  • Wellcome Trust
  • Novo Nordisk Fonden

Zitieren

APA

Authier, F., Ondruskova, N., Ferenbach, A. T., McNeilly, A. D., & van Aalten, D. M. F. (2024). Neurodevelopmental defects in a mouse model of O- GlcNAc transferase intellectual disability. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050671

Vancouver

Authier F, Ondruskova N, Ferenbach AT, McNeilly AD, van Aalten DMF. Neurodevelopmental defects in a mouse model of O- GlcNAc transferase intellectual disability. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050671

BibTeX
@article{Authier2024,
  author = {Authier, Florence and Ondruskova, Nina and Ferenbach, Andrew T and McNeilly, Alison D and van Aalten, Daan M F},
  title = {Neurodevelopmental defects in a mouse model of O- GlcNAc transferase intellectual disability},
  journal = {Disease Models & Mechanisms},
  year = {2024},
  doi = {10.1242/dmm.050671}
}
Kostenlos starten →